Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dynamic Glucose Enhanced MRI for Metastatic Brain Tumors
NCT02796729Phase 2Terminated
- Sponsor
- BC Cancer
- Start
- Oct 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by BC Cancer. Primary endpoint: Integral tumour contrast assessed using Area Under Curve at 1 hour. Started Oct 2016; status: terminated.
Beyond the preview
Go deeper on NCT02796729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02796729.